Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Acute myocardial infarction (AMI) remains a major global health challenge with high mortality rates. This study investigated the association between platelet count and 30-day in-hospital mortality in critically ill AMI patients. This multicenter retrospective cohort study analyzed 6,850 critically ill AMI patients from 208 U.S. hospitals (2014-2015) using the eICU Collaborative Research Database v2.0. The primary exposure was baseline platelet count within 24 h of ICU admission. The primary outcome was 30-day in-hospital mortality. Analyses were adjusted for demographics, laboratory parameters, disease severity, comorbidities, and treatments. A U-shaped relationship was identified between platelet count and mortality, with an inflection point at 147 × 10⁹/L. Below this threshold, each 10 × 10⁹/L increase in platelet count was associated with decreased mortality (OR = 0.931, 95% CI: 0.892-0.973, P = 0.001). Above the threshold, each 10 × 10⁹/L increase was associated with increased mortality (OR = 1.023, 95% CI: 1.010-1.036, P < 0.001). A U-shaped relationship was observed between platelet count and 30-day in-hospital mortality in critically ill AMI patients, with optimal outcomes observed at approximately 147 × 10⁹/L, suggesting that platelet count may serve as a potential risk stratification marker.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12216307PMC
http://dx.doi.org/10.1038/s41598-025-06317-xDOI Listing

Publication Analysis

Top Keywords

platelet count
20
30-day in-hospital
12
in-hospital mortality
12
count 30-day
8
acute myocardial
8
myocardial infarction
8
multicenter retrospective
8
retrospective cohort
8
cohort study
8
critically ill
8

Similar Publications

Backround: Leukemia is the most common childhood malignancy and often presents with nonspecific symptoms, which may lead to delays in diagnosis. Early recognition of clinical signs and laboratory abnormalities is essential to ensure timely referral and improve outcomes. This study assesses the clinical and laboratory characteristics of pediatric patients with acute and relapsed leukemia, points out key considerations during diagnosis, and investigates potential factors contributing to delayed diagnosis.

View Article and Find Full Text PDF

A rare pediatric case of immune thrombocytopenia attributed to brucellosis.

Turk J Pediatr

September 2025

Department of Pediatric Hematology and Oncology, Batman Training and Research Hospital, Batman, Türkiye.

Background: Brucellosis is a zoonotic infection transmitted to humans by ingestion of contaminated unpasteurized dairy products or via direct or indirect contact with infected animals. It is characterized by nonspecific symptoms like fever and joint pain, and laboratory findings including anemia, leukopenia, thrombocytopenia, or rarely pancytopenia. Here we report a case of brucellosis with thrombocytopenia that did not improve despite anti-brucella treatment and required intravenous immunoglobulin treatment.

View Article and Find Full Text PDF

Objective: To evaluate clinical and laboratory effectiveness of ultrasound treatment for purulent wounds.

Material And Methods: The study enrolled 46 patients with purulent wounds divided into the main group (23 patients, ultrasonic treatment) and the control group (23 patients, traditional treatment). We assessed treatment effectiveness considering visual data, quality of granulation tissue, wound defect area and marginal epithelialization, complete blood count and C-reactive protein.

View Article and Find Full Text PDF

Background: Nucleophosmin 1 (NPM1) mutations represent one of the most frequent genetic alterations in acute myeloid leukemia (AML). However, the prognostic significance of concurrent molecular abnormalities and clinical features in NPM1-mutated AML remains to be fully elucidated.

Methods: We retrospectively analyzed 73 adult AML patients with NPM1 mutations.

View Article and Find Full Text PDF

Background: Based on the widespread use of the systemic immune-inflammation index (SII), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR), markers, we aimed to calculate and compare the reference intervals (RIs) of these indices in adults, using both nonparametric method according to the Clinical and Laboratory Standards Institute's (CLSI) EP28-A3C:2010 guideline and refineR algorithm using a large dataset.

Methods: We analyzed data from 293,585 adults (18 - 65 years) retrospectively obtained from complete blood count results (using laboratory information system). The study involved a two-stage outlier exclusion process.

View Article and Find Full Text PDF